Please use this identifier to cite or link to this item:
|Title:||Implications of New Patent Regime on Indian Pharmaceutical Industry: Challenges and Opportunities|
|Keywords:||Pharmaceutical industry;Indian Patent Act;new patent regime;product patent;TRIPS Agreement|
|Abstract:||The growth of Indian pharmaceutical industry has been characterized by extensive governmental control and absence of strong patent protection. This paper gives an overview of pharmaceutical industry in India and the likely impact of product patent regime on it. The analysis is based on secondary data published elsewhere. It also reviews the existing patent and drug control laws in India and how they have affected the growth and structure of pharmaceutical industry in the country. Also discussed are strategies to meet the new challenges and the opportunities that Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement presents to pharmaceutical industry in India.|
|Appears in Collections:||JIPR Vol.10(4) [July 2005]|
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.